New England Journal of Medicine, Volume 381, Issue 9, Page 890-890, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 852-861, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 800-801, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 882-884, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 875-881, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 863-871, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 793-795, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 796-798, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 887-889, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Volume 381, Issue 9, Page 862-862, August 2019.
Wed Aug 28, 2019 12:00
New England Journal of Medicine, Ahead of Print.
Wed Aug 28, 2019 12:00
Mark above section as read
Charcot–Leyden crystals have been observed in the airway mucus of patients with allergic airway disease since the 19th century, but their role in the pathogenesis of allergy has been unclear. Charcot–Leyden crystals and lysophospholipase are abundant in eosinophils and basophils, and originally, it…
Mark above section as read
Presentation of Case. Dr. Hung M. Le (Pediatrics): A 16-year-old girl was seen in the sports concussion clinic at this hospital because of headache, dizziness, balance problems, fatigue, irritability, and difficulties with sleep and concentration after she had head trauma during a sailboat race.…
Mark above section as read
Mark above section as read
Mark above section as read
Glucocorticoid replacement therapy, available since the 1950s, has prolonged the survival of patients with adrenal insufficiency. However, adrenal crises, which are life-threatening medical emergencies, still develop in many affected patients. Adrenal crisis appears to be increasing in frequency,…
Mark above section as read
Cardiovascular disease is the primary cause of death in patients with type 2 diabetes, and the ruling out of an excess cardiovascular risk is a regulatory requirement for new glucose-lowering therapies. Glucagon-like peptide-1 (GLP-1) receptor agonists are well-established glucose-lowering…
Mark above section as read
Mark above section as read
At my mother’s first oncology appointment, I sat beside her, swaddled in my Harvard sweatshirt. I hoped that the name of the august institution where I was an undergraduate would, in the doctor’s eyes, transport my mother from the wasteland of "difficult," "noncompliant," and "welfare queen" to…
Thu Aug 29, 2019 03:00
The treatment of children has been pivotal in the development of laws ensuring that medications are tested for safety and efficacy before widespread use. The first law imposing federal regulations of biologic products was the Biologics Control Act of 1902, which was enacted in response to the…
Thu Aug 29, 2019 03:00
Approximately 174 people die from drug overdoses in the United States each day, and opioids are the most common culprit. In 2017, one of those people was a first-year student at the University of California, San Francisco, School of Medicine, where we work. Although the immediate cause of death was…
Thu Aug 29, 2019 03:00
The ongoing overdose crisis has spared no demographic, professional, or geographic stratum. Although efforts to bring substance use disorder and its treatment out of the shadows have made substantial inroads, outdated thinking, policies, and practices persist. Recently, two nurses were found dead…
Thu Aug 29, 2019 03:00
Mark above section as read
Mark above section as read
To the Editor: The human immunodeficiency virus type 1 (HIV-1) integrase inhibitor dolutegravir is recommended in treatment guidelines as first-line therapy for HIV-1 infection and is characterized by high antiviral potency and a high genetic barrier to the emergence of resistance. Few cases of…
Mark above section as read
Mark above section as read
Figure 1.
Thu Aug 29, 2019 03:00
Mark above section as read
In October 2018, Alin Gragossian, an emergency medicine resident at Philadelphia’s Hahnemann University Hospital, developed a cough. She thought little of it until, a few months later, her attending physician on an ICU rotation noticed that she was stopping to catch her breath between sentences.…
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου